Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression.
about
Matrin 3 is a co-factor for HIV-1 Rev in regulating post-transcriptional viral gene expressionIncreased immune response elicited by DNA vaccination with a synthetic gp120 sequence with optimized codon usageLEDGF/p75 determines cellular trafficking of diverse lentiviral but not murine oncoretroviral integrase proteins and is a component of functional lentiviral preintegration complexesHuman immunodeficiency virus type 1 Rev is required in vivo for binding of poly(A)-binding protein to Rev-dependent RNAsThe basic domain of Rev from human immunodeficiency virus type 1 specifically blocks the entry of U4/U6.U5 small nuclear ribonucleoprotein in spliceosome assemblyEukaryotic initiation factor 5A is a cellular target of the human immunodeficiency virus type 1 Rev activation domain mediating trans-activationHIV-1 Rev oligomerization is not obligatory in the presence of an extra basic domainRTE and CTE mRNA export elements synergistically increase expression of unstable, Rev-dependent HIV and SIV mRNAsInteractions between the HIV-1 Unspliced mRNA and Host mRNA Decay MachineriesThe human immunodeficiency virus type 1 Rev protein shuttles between the cytoplasm and nuclear compartments.Human immunodeficiency virus env expression becomes Rev-independent if the env region is not defined as an intronAvian retroviral RNA element promotes unspliced RNA accumulation in the cytoplasmNuclear interactions are necessary for translational enhancement by spleen necrosis virus RU5.The 5' RNA terminus of spleen necrosis virus contains a novel posttranscriptional control element that facilitates human immunodeficiency virus Rev/RRE-independent Gag production.Rev proteins of human and simian immunodeficiency virus enhance RNA encapsidation.Regulation of HIV-Gag expression and targeting to the endolysosomal/secretory pathway by the luminal domain of lysosomal-associated membrane protein (LAMP-1) enhance Gag-specific immune response.Control of human immunodeficiency virus type 1 RNA metabolism: role of splice sites and intron sequences in unspliced viral RNA subcellular distribution.The 5' RNA terminus of spleen necrosis virus stimulates translation of nonviral mRNAContributions of viral splice sites and cis-regulatory elements to lentivirus vector function.Identification of two sequences in the cytoplasmic tail of the human immunodeficiency virus type 1 envelope glycoprotein that inhibit cell surface expressionIntronless mRNA transport elements may affect multiple steps of pre-mRNA processing.Nuclear RNA export and packaging functions of HIV-1 Rev revisitedRU5 of Mason-Pfizer monkey virus 5' long terminal repeat enhances cytoplasmic expression of human immunodeficiency virus type 1 gag-pol and nonviral reporter RNA.A cis-acting element present within the Gag open reading frame negatively impacts on the activity of the HIV-1 IRES.The retrovirus RNA trafficking granule: from birth to maturity.Rev of human immunodeficiency virus and Rex of the human T-cell leukemia virus type I can counteract an mRNA downregulatory element of the transferrin receptor mRNA.Identification of RNA instability elements in Borna disease virusMechanism of action of regulatory proteins encoded by complex retrovirusesA cis-acting repressive sequence that overlaps the Rev-responsive element of human immunodeficiency virus type 1 regulates nuclear retention of env mRNAs independently of known splice signals.HIV DNA Vaccine: Stepwise Improvements Make a Difference.The Rev protein of human immunodeficiency virus type 1 counteracts the effect of an AU-rich negative element in the human papillomavirus type 1 late 3' untranslated region.Nuclear export of the human immunodeficiency virus type 1 nucleocytoplasmic shuttle protein Rev is mediated by its activation domain and is blocked by transdominant negative mutantsEfficient expression of the human papillomavirus type 16 L1 protein in epithelial cells by using Rev and the Rev-responsive element of human immunodeficiency virus or the cis-acting transactivation element of simian retrovirus type 1Polypyrimidine tract-binding protein and heterogeneous nuclear ribonucleoprotein A1 bind to human T-cell leukemia virus type 2 RNA regulatory elements.Possible role of splice acceptor site in expression of unspliced gag-containing message of Moloney murine leukemia virus.Inhibitory activity of the equine infectious anemia virus major 5' splice site in the absence of Revcis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations.The rev-responsive element negatively regulates human immunodeficiency virus type 1 env mRNA expression in primate cells.The posttranscriptional control element of the simian retrovirus type 1 forms an extensive RNA secondary structure necessary for its function.Human immunodeficiency virus type 1 Rev function requires continued synthesis of its target mRNA
P2860
Q24315683-3CAC7EC1-42FA-4439-882C-9C496FF44464Q24531468-DE8FF24F-9787-4E83-B256-D98A88F68F03Q24562936-963CB734-6658-4C61-AFFC-3885A5970317Q24645943-E94F9963-FCF9-4E2D-92A9-7F8B2827C4A0Q24656044-C9AA7A2B-6CFD-4B1B-9D13-41CCEE01D136Q24657633-5ACC5EE6-67C2-4A99-9932-F4C02FFB668BQ24814560-EE5EC925-282D-4DBD-B2B5-BFEDF535E062Q25256626-932C1EA0-FBDD-4915-A797-736805B8FAB2Q28078564-C4D25FED-CAF6-41A5-BDF2-04354A2AA92BQ30450201-5503539D-48DB-4F17-9641-41D11A057F96Q30452134-C42F777A-3131-4EE8-9D2B-05772C4598E9Q30452592-E27882FF-424A-41BB-BB48-6E82033BD9A8Q30453281-2AB687D8-394A-4221-907F-18DBC017EC17Q30453503-4715ED02-5F97-4268-9630-8640B61BA08CQ33282047-6BC5E6B8-C2E8-49FB-94D1-EA31A356F2CFQ33763297-66DA5DBF-48FE-4945-B937-2B7AA13CA55EQ33785931-93F49174-F6CE-4C4C-9FF5-C86F10C05FA4Q33810910-2BB8A194-CF0C-4EF6-94AF-0C15C41464BFQ33816167-A65C8A24-E202-479D-B1A3-E130D58285A9Q33851952-E0FFB500-D0EA-4E85-8A4B-B8A4B51A51B3Q33890618-6E4C1C99-CF56-4C06-8415-F10A4BEE1CE4Q33990559-74EE075E-9ADC-4C21-BD3B-BEFF375C990AQ34348421-51EF0132-C3C1-458D-9F72-8F405B2A20E9Q34602786-82B8BD06-0CC5-44A0-896E-3DDCA0DF6E91Q34667412-E78D18DC-534A-4FE3-94C6-01DAE175C9D7Q34894843-2240DA96-4C6D-4B85-87B3-F13B014F5504Q35027432-07F4AAA7-BC00-4F98-8B18-65F6ED041848Q35403061-3147BB8D-CE2E-495A-96E7-40A6C45019A2Q35694388-1DE2D687-6E33-4EBB-BABC-617D3FFEBBF3Q35826742-3407AD8F-FAA9-40BD-9A58-B1BA0F7E1820Q35838834-E76669BC-3BB7-4E59-A4FE-54E37FBFA23EQ35839437-879F789B-0B79-4215-90D1-91E4EAC414C3Q35845879-77289914-8F15-43AD-A455-0B98E378C42CQ35850283-DD7244A8-FF2B-4328-B63B-22364F41E5F2Q35858761-9B1C04E7-FB48-4D31-A3A2-88D9C3439374Q35861329-6B657ECA-0733-4258-8DD6-8B4130D3CF36Q35864679-A51F8A6E-F212-40A9-A24A-88EF5FFF5D51Q35867631-64CFD4B5-CF32-4984-A8E9-3B9EBD148082Q35868005-678128F6-191D-4EFC-94A2-B782DEFAF6B3Q35873164-311B4E0A-AB5C-4041-A93A-8C76A6E0F2CD
P2860
Identification and characterization of intragenic sequences which repress human immunodeficiency virus structural gene expression.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年論文
@yue
1991年論文
@zh-hant
1991年論文
@zh-hk
1991年論文
@zh-mo
1991年論文
@zh-tw
1991年论文
@wuu
1991年论文
@zh
1991年论文
@zh-cn
name
Identification and characteriz ...... us structural gene expression.
@en
type
label
Identification and characteriz ...... us structural gene expression.
@en
prefLabel
Identification and characteriz ...... us structural gene expression.
@en
P2093
P2860
P1433
P1476
Identification and characteriz ...... us structural gene expression.
@en
P2093
P2860
P304
P407
P577
1991-10-01T00:00:00Z